Title :

Characterization of the first peptide ligand targeting the MUC4EGF domains in the MUC4-ErbB2 complex in pancreatic cancer.

Author(s) :

Stoup, Nicolas [Auteur]
Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Liberelle, Maxime [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Renault, Nicolas [Auteur]
Institute for Translational Research in Inflammation - U 1286 [INFINITE]
Melnyk, Patricia [Auteur]
Institut de Chimie Pharmaceutique Albert Lespagnol [ICPAL]
Université de Lille
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Jonckheere, Nicolas [Auteur]
Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Lebègue, Nicolas [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Van Seuningen, Isabelle [Auteur]
Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]

Conference title :

3rd ONCOLille phD Days (3 ème journée des doctorants ONCOLille)

Conference organizers(s) :

ONCOLille

City :

Lille

Country :

France

Start date of the conference :

2022-03-16

English keyword(s) :

Pancreactic cancer, ErbB2, MUC4, EGF domains, inhibitory peptide

HAL domain(s) :

Sciences du Vivant [q-bio]
Chimie/Chimie thérapeutique
Sciences du Vivant [q-bio]/Biochimie, Biologie Moléculaire
Sciences du Vivant [q-bio]/Biologie cellulaire
Sciences du Vivant [q-bio]/Cancer

Language :

Anglais

Peer reviewed article :

Oui

Audience :

Internationale

Popular science :

Non

Collections :

• Cancer Heterogeneity, Plasticity and Resistance to Therapies (CANTHER) - UMR 9020 - UMR 1277

Source :

Harvested from HAL